|
US5296230A
(en)
*
|
1985-02-25 |
1994-03-22 |
Rutgers, The State University Of New Jersey |
Transdermal fertility control system and process
|
|
US5145682A
(en)
*
|
1986-05-30 |
1992-09-08 |
Rutgers, The State University Of New Jersey |
Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
|
|
US5560922A
(en)
*
|
1986-05-30 |
1996-10-01 |
Rutgers, The State University Of New Jersey |
Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
|
|
AU607172B2
(en)
*
|
1986-12-22 |
1991-02-28 |
Cygnus, Inc. |
Diffusion matrix for transdermal drug administration
|
|
US5023084A
(en)
*
|
1986-12-29 |
1991-06-11 |
Rutgers, The State University Of New Jersey |
Transdermal estrogen/progestin dosage unit, system and process
|
|
US5256421A
(en)
*
|
1987-09-24 |
1993-10-26 |
Jencap Research Ltd. |
Hormone preparation and method
|
|
US5276022A
(en)
*
|
1987-09-24 |
1994-01-04 |
Jencap Research Ltd. |
Hormone preparation and method
|
|
US4994278A
(en)
*
|
1988-03-04 |
1991-02-19 |
Noven Pharmaceuticals, Inc. |
Breathable backing
|
|
DE3823070A1
(de)
*
|
1988-07-07 |
1990-02-22 |
Kettelhack Riker Pharma Gmbh |
Selbstklebendes heftpflaster
|
|
US5200190A
(en)
*
|
1988-10-11 |
1993-04-06 |
Sekisui Kagaku Kogyo Kabushiki Kaisha |
Percutaneous pharmaceutical preparation
|
|
US5332577A
(en)
*
|
1988-12-27 |
1994-07-26 |
Dermamed |
Transdermal administration to humans and animals
|
|
US5241925A
(en)
*
|
1988-12-27 |
1993-09-07 |
Dermamed |
Apparatus and techniques for administering veterinary medicaments
|
|
US5053227A
(en)
*
|
1989-03-22 |
1991-10-01 |
Cygnus Therapeutic Systems |
Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
|
|
US5059426A
(en)
*
|
1989-03-22 |
1991-10-22 |
Cygnus Therapeutic Systems |
Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
|
|
US4973468A
(en)
*
|
1989-03-22 |
1990-11-27 |
Cygnus Research Corporation |
Skin permeation enhancer compositions
|
|
US5788983A
(en)
*
|
1989-04-03 |
1998-08-04 |
Rutgers, The State University Of New Jersey |
Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
|
|
US5252334A
(en)
*
|
1989-09-08 |
1993-10-12 |
Cygnus Therapeutic Systems |
Solid matrix system for transdermal drug delivery
|
|
DE3933460A1
(de)
*
|
1989-10-06 |
1991-04-18 |
Lohmann Therapie Syst Lts |
Oestrogenhaltiges wirkstoffpflaster
|
|
US5096715A
(en)
*
|
1989-11-20 |
1992-03-17 |
Alko Ltd. |
Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist
|
|
US5324521A
(en)
*
|
1989-12-18 |
1994-06-28 |
Dermamed |
Systems for transdermal administration of medicaments
|
|
US5158978A
(en)
*
|
1990-02-05 |
1992-10-27 |
British Technology Group (U.S.A.) |
Thyroid hormone treatment of acute cardiovascular compromise
|
|
EP1093816A3
(en)
*
|
1990-06-01 |
2003-10-22 |
The Population Council, Inc. |
Use of ST1435 in hormonal therapy by transdermal application
|
|
US5627035A
(en)
*
|
1990-08-22 |
1997-05-06 |
Syntello Vaccine Development Ab |
Peptides that block human immunodeficiency virus and methods of use thereof
|
|
IT1243745B
(it)
*
|
1990-10-17 |
1994-06-21 |
Vectorpharma Int |
Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
|
|
US5198223A
(en)
*
|
1990-10-29 |
1993-03-30 |
Alza Corporation |
Transdermal formulations, methods and devices
|
|
US5320850A
(en)
*
|
1990-10-29 |
1994-06-14 |
Alza Corporation |
Transdermal delivery of the gestogen ST-1435 and devices therefor
|
|
MX9101787A
(es)
*
|
1990-10-29 |
1992-06-05 |
Alza Corp |
Formulaciones,metodos y dispositivos anticonceptivos transdermicos
|
|
US5705185A
(en)
*
|
1991-09-25 |
1998-01-06 |
Beta Pharmaceuticals Co. |
Transdermal delivery of estradiol and process for manufacturing said device
|
|
US5518734A
(en)
*
|
1991-09-25 |
1996-05-21 |
Beta Pharmaceuticals Co. |
Transdermal delivery system for estradiol and process for manufacturing said device
|
|
JP2960832B2
(ja)
*
|
1992-05-08 |
1999-10-12 |
ペルマテック テクノロジー アクチェンゲゼルシャフト |
エストラジオールの投与システム
|
|
DE4309830C1
(de)
*
|
1993-03-26 |
1994-05-05 |
Lohmann Therapie Syst Lts |
Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
|
|
US5759548A
(en)
*
|
1993-11-30 |
1998-06-02 |
Lxr Biotechnology Inc. |
Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
|
|
AU692504B2
(en)
*
|
1993-12-27 |
1998-06-11 |
Akzo Nobel N.V. |
Percutaneously absorbable preparation
|
|
PT781122E
(pt)
|
1994-09-14 |
2000-11-30 |
Minnesota Mining & Mfg |
Matriz para a distribuicao transdermica de farmacos
|
|
US5785991A
(en)
*
|
1995-06-07 |
1998-07-28 |
Alza Corporation |
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
|
|
UA48973C2
(uk)
*
|
1995-06-07 |
2002-09-16 |
Орто-Макнейл Фармасьютікалз Інк. |
Трансдермальний пластир на основі 17-деацетилноргестимату для попередження овуляції
|
|
US6063757A
(en)
*
|
1995-11-29 |
2000-05-16 |
Urso; Richard G. |
Wound treatment method with nerve growth factor
|
|
US5762956A
(en)
*
|
1996-04-24 |
1998-06-09 |
Rutgers, The State University Of New Jersey |
Transdermal contraceptive delivery system and process
|
|
US6495532B1
(en)
*
|
1997-03-19 |
2002-12-17 |
Sky High, Llc |
Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
|
|
US6949528B1
(en)
|
1998-03-18 |
2005-09-27 |
Goddard John G |
Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
|
|
US6190699B1
(en)
|
1998-05-08 |
2001-02-20 |
Nzl Corporation |
Method of incorporating proteins or peptides into a matrix and administration thereof through mucosa
|
|
US6818612B2
(en)
|
1998-11-24 |
2004-11-16 |
Kristina Broliden |
Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
|
|
US6743772B1
(en)
|
1998-11-24 |
2004-06-01 |
Kristina Broliden |
Use of parovirus capsid particles in the inhibition of cell proliferation and migration
|
|
US6153850A
(en)
|
1999-04-29 |
2000-11-28 |
The Esab Group, Inc. |
Method of cutting a workpiece along an arcuate path with a plasma arc torch
|
|
US6680176B2
(en)
*
|
1999-05-17 |
2004-01-20 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Identification of candidate ligands which modulate antigen presenting cells
|
|
JP4428899B2
(ja)
*
|
1999-07-02 |
2010-03-10 |
エルテーエス ローマン テラピー−ジステーメ アーゲー |
ポリシロキサンおよび両親和性溶媒を基にした微小貯蔵所系
|
|
US6258932B1
(en)
|
1999-08-09 |
2001-07-10 |
Tripep Ab |
Peptides that block viral infectivity and methods of use thereof
|
|
US7384650B2
(en)
|
1999-11-24 |
2008-06-10 |
Agile Therapeutics, Inc. |
Skin permeation enhancement composition for transdermal hormone delivery system
|
|
DE10003767A1
(de)
*
|
2000-01-28 |
2001-10-04 |
Beiersdorf Ag |
Hautfreundliches Wirkstoffpflaster zur transdermalen Verabreichung nichtsteroidaler Antirheumatika
|
|
US20060063738A1
(en)
*
|
2000-02-28 |
2006-03-23 |
Sky High, Llc |
Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
|
|
JP2001240236A
(ja)
*
|
2000-03-01 |
2001-09-04 |
Shikoku Kakoki Co Ltd |
コンベヤ
|
|
US6680059B2
(en)
*
|
2000-08-29 |
2004-01-20 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
|
RU2286172C2
(ru)
*
|
2000-08-17 |
2006-10-27 |
Трипеп Аб |
Вакцины, содержащие рибавирин, и способы их использования
|
|
US7022830B2
(en)
*
|
2000-08-17 |
2006-04-04 |
Tripep Ab |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
|
|
WO2002014362A2
(en)
|
2000-08-17 |
2002-02-21 |
Tripep Ab |
A hepatitis c virus non-structural ns3/4a fusion gene
|
|
US7011965B2
(en)
|
2001-03-09 |
2006-03-14 |
Regents Of The University Of Minnesota |
Compositions and methods for stimulating wound healing and fibroblast proliferation
|
|
EP1436317A1
(en)
*
|
2001-09-19 |
2004-07-14 |
Tripep Ab |
Molecules that block viral infectivity and methods of use thereof
|
|
US20030162202A1
(en)
*
|
2001-11-09 |
2003-08-28 |
Becker Kenneth David |
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
|
|
US20040067512A1
(en)
*
|
2001-11-09 |
2004-04-08 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
|
|
DE20217814U1
(de)
*
|
2002-11-18 |
2004-04-08 |
Asat Ag Applied Science & Technology |
Melatonin-Tagesdosierungseinheiten
|
|
MXPA05004537A
(es)
*
|
2002-10-30 |
2005-11-23 |
Asat Ag Applied Science & Tech |
Formulaciones conteniendo melatonina, ginkgo biloba y biotina.
|
|
US7048914B2
(en)
*
|
2002-12-12 |
2006-05-23 |
Zoltan Laboratories |
Placental alkaline phosphatase to control diabetes
|
|
EP1594898A2
(en)
|
2003-02-06 |
2005-11-16 |
Tripep AB |
Glycosylated specificity exchangers
|
|
US20050096319A1
(en)
*
|
2003-02-21 |
2005-05-05 |
Balzarini Jan M.R. |
Identification of compounds that inhibit replication of human immunodeficiency virus
|
|
JP2006518373A
(ja)
*
|
2003-02-21 |
2006-08-10 |
トリペップ アクチ ボラゲット |
Ｈｉｖ複製を抑制するためのグリシンアミド誘導体
|
|
US7374754B2
(en)
*
|
2003-09-02 |
2008-05-20 |
Essential Skincare, Llc |
Use of placental alkaline phosphatase to promote skin cell proliferation
|
|
US20060228753A1
(en)
*
|
2004-07-12 |
2006-10-12 |
Andrew Levy |
Methods of detecting a phenotype of a polymorphic protein
|
|
ATE514708T1
(de)
|
2004-08-27 |
2011-07-15 |
Chrontech Pharma Ab |
Transgene mausmodelle des hepatitis c virus (hcv) sowie identifizierung von hcv therapeutika
|
|
WO2007031867A2
(en)
|
2005-05-25 |
2007-03-22 |
Tripep Ab |
A hepatitis c virus non-stru tural ns3/4a fusion gene
|
|
WO2007032818A2
(en)
*
|
2005-09-12 |
2007-03-22 |
Zoltan Laboratories Llc |
Compounds and compositions to control abnormal cell growth
|
|
EP1965830B1
(en)
*
|
2005-12-28 |
2014-05-14 |
Zoltan Laboratories Llc |
Use of alkaline phosphatase to maintain healthy tissue mass in mammals
|
|
US7718170B2
(en)
*
|
2006-08-21 |
2010-05-18 |
Essential Skincare, Llc |
Alkaline phosphatase compositions to reduce skin cancer
|
|
US8383589B2
(en)
|
2007-07-09 |
2013-02-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Aegyptin and uses thereof
|
|
US20090214593A1
(en)
*
|
2007-08-16 |
2009-08-27 |
Tripep Ab |
Immunogen platform
|
|
US8071561B2
(en)
*
|
2007-08-16 |
2011-12-06 |
Chrontech Pharma Ab |
Immunogen platform
|
|
DE102009056745A1
(de)
*
|
2009-12-04 |
2011-06-09 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System für die Verabreichung von Peptiden
|
|
US9241944B2
(en)
|
2010-06-16 |
2016-01-26 |
Institut National De La Santé Et De La Recherche Médicale (Inserm) |
Methods and compositions for stimulating reepithelialisation during wound healing
|
|
WO2020239623A1
(en)
|
2019-05-24 |
2020-12-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of ngal inhibitors for the treating chronic wound
|